Cambridge NeuroScience, CeNeS deal

CEN completed its previously announced acquisition of CNSI for 42.6 million CEN shares, valued at $36.4 million based on CEN's Friday close of 58p (see BioCentury, May 30, 2000). The merged company will focus on central nervous system disorders and pain control. ...